Michael Cordonnier - 22 Jul 2025 Form 4 Insider Report for CARLSMED, INC.

Reporting relationship: CEO, President, Director
Issuer ticker: CARL on Nasdaq
Reported as of: 22 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jul 2025, 20:33:12 UTC
Next SEC filing: 30 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Cordonnier

Key filing fact

Michael Cordonnier filed Form 4 for CARLSMED, INC. on 24 Jul 2025.

Key facts

This page summarizes Michael Cordonnier's Form 4 filing for CARLSMED, INC..
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 24 Jul 2025, 20:33.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002077087 Primary reporting owner

Cordonnier Michael

Relationship: CEO, President, Director
Address: C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature: /s/ Michael Cordonnier
Signature date: 24 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,612
Change %: +0.29%
Price
Shares after: 1,239,330
Date: 24 Jul 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CARL transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value: $0
Shares: +142,857
Change %: +24%
Price: $0.000000
Shares after: 726,235
Date: 22 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 142,857
Exercise price: $15.00
Footnotes: F2

CARL transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares: -3,612
Change %: -100%
Price
Shares after: 0
Date: 24 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,612
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

Footnote F2

The unvested stock options are convertible into approximately 142,857 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the "Grant Date"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date.